Innovation
is our nature

Discover our research

Exscalate: the future is already here

One of the most powerful intelligent supercomputing platforms in the world

discover more

Health sector, no to generic supports, but yes to a real selection

The Sole 24 Ore interview with Sergio Dompé, Executive President of Dompé pharmaceuticals: «The strategy to follow is founded on selection based on effectiveness and the ability to be competitive. Those who are more skilled must be allowed to collect better results."

Read the article

The Dompé of tomorrow

Our future according to Nathalie Dompé, CEO of Dompé Pharmaceuticals, Vice President of Business Development Dompé US and Shareholder of the Dompé group

discover more

Drug Discovery

Dompé farmaceutici has seized the potential of bioinformatics by developing various drug discovery platforms.

Dompé in the media

Read the articles

Neurotrophins

Our therapy based on Cenegermin Nerve Growth Factor has been awarded Breakthrough Therapy designation by the FDA and has received marketing authorization in Europe, the US, and China.

discover more

We are hiring

People: our most valuable asset. That’s why we promote their professional development.

CHECK OUT OUR OPEN POSITIONS

Pipeline

With our research and development pipeline, we target some of the highest-needing therapeutic areas.

Dompé Foundation

We nurture and develop talent to push the boundaries of knowledge further

discover more

Research, development and production contributing to innovation

Alongside our manufacturing activities, our hub in L’Aquila also accommodates a number of research facilities covering the whole Drug Discovery process for small molecules and biotech drugs, from the early stage to clinical development and patient administration.

Discover our production hub

8 production lines

7 synthesis, 1 biotech

60 million

manufactured packages per year

CDMO facility

synthesis and biotech

27 clinical trials

over 200 patients

Dompé logo

Dompé farmaceutici S.p.A. Single shareholder company / Share capital € 50.000.000,00
REA MI 289519 - A registered company in Milan, Italy / Tax code and VAT number IT00791570153

Close